How does the EU encourage pharmaceutical innovation?
Ben Brigou and Jaap Mannaerts of NLO examine the different incentives the EU offers in order to encourage pharmaceutical innovation, including SPCs, regulatory measures and the Bolar exemption
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: